Takeuchi Pharmaceutical Co., Ltd. | Soins de la Peau / Soins CapillairesOEM/ODM Manufacturing (Tokyo)

À Propos de la Fabrication OEM de Takeuchi Pharmaceutical Co., Ltd.

Founded in 2013, a cosmetics and quasi-drug OEM manufacturer. With over 500 OEM contract achievements, the company internalizes all processes from raw material selection to formulation design, manufacturing, filling, packaging, and shipping. Handles small lots from as few as 100 units.

Activités Commerciales de Takeuchi Pharmaceutical Co., Ltd.

• Takeuchi Pharmaceutical Co.
• Ltd. manufactures and sells cosmetics
• quasi-drugs
• medical devices
• and food additives. The company offers comprehensive contract manufacturing services (OEM/ODM) encompassing the entire value chain from planning through sales for cosmetics and health foods.

Caractéristiques & Points Forts de Takeuchi Pharmaceutical Co., Ltd.

• All processes in-house
• Multiple Tokyo factories
• Strong in hair-removal products

Spécialités de Takeuchi Pharmaceutical Co., Ltd.

• Skincare
• Hair care
• Body care
• Oral care
• CBD cosmetics

Certifications & Équipements de Takeuchi Pharmaceutical Co., Ltd.

Réalisations de Takeuchi Pharmaceutical Co., Ltd.

Implantations de Takeuchi Pharmaceutical Co., Ltd.

Historique de l'Entreprise Takeuchi Pharmaceutical Co., Ltd.

• —

  Founded as Virgin Japan Co., Ltd. in June 2013, the company opened its flagship wax hair removal specialty store Virgin Wax in Ikebukuro in August of the same year. In September 2015, the product manufacturing and sales division was separated to establish Lipika Co., Ltd., and the Adachi Odai Plant (now Kanto Second Plant) was completed. In September 2016, the manufacturing division was incorporated as a subsidiary, establishing Takeuchi Pharmaceutical Co., Ltd., which obtained manufacturing and sales licenses for cosmetics and quasi-drugs in January 2017. The company subsequently obtained medical device manufacturing license in March 2019, relocated its headquarters to Higashi-Gotanda, Shinagawa Ward in May 2019, obtained food additive manufacturing license in September 2019, completed the Tokyo Towa Plant (now Kanto First Plant) in October 2019, and obtained high-risk medical device sales license in November 2019. In December 2021, the headquarters was relocated to Nishi-Gotanda, Shinagawa Ward. In September 2022, the company joined the O-IZumi Group (TSE Prime Market: 6428).

Sociétés du Groupe Takeuchi Pharmaceutical Co., Ltd.

Catégories Supportées par Takeuchi Pharmaceutical Co., Ltd.

Learn about this category

FAQ sur Takeuchi Pharmaceutical Co., Ltd.